Recombinant Anti-SARS-CoV-2 Neutralizing Antibody (V3S-0523-XY77) (CAT#: V3S-0523-XY77)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a neutralizing antibody that binds to Severe Acute Respiratory Syndrome Coronavirus 2. S2H14 recognizes the RBD and S2H14 competed with ACE2 for recognition of the SARS-CoV-2 RBD indicating that S2H14 likely neutralizes SARS-CoV-2 through inhibition of virus/host cell interaction.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2
Epitope RBD receptor binding domain
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA
Application Notes Spectraplate-384 with high protein binding treatment were coated overnight at 4°C with 1 μg/mL of SARS-CoV-2 S, domain A, N, S2, SARS-CoV S or 5 μg/mL of SARS-CoV-2/SARS-CoV RBD in PBS, pH 7.2, and plates were subsequently blocked with Blocker Casein (1%) in PBS supplemeted with 0.05% Tween 20. The coated plates were incubated with serial dilutions of human mAbs or human plasma or sera for 1 h at room temperature. The plates were then washed with PBS-T, and Alkaline Phosphatase-conjugated Goat Anti-Human IgG, IgM or IgA were added and incubated for 1 h. Plates were washed three times with PBS-T, and 4-NitroPhenyl Phosphate substrate was added and incubated for 1 h (IgG) or 2 h (IgA and IgM). The absorbance of 405 nm was measured by a microplate reader, and the data was plotted with Graph Prism software.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target SARS-CoV-2
Alternative Name Severe acute respiratory syndrome coronavirus 2
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry